Ernesta Dammassa

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Hui Gao, Joshua M. Korn, Stéphane Ferretti et al. · Nature Medicine · 2015 · 1.4K citations

Medicine, Oncology, Pharmacology +12

CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms

Sara C. Meyer, Matthew D. Keller, Sophia Chiu et al. · Cancer Cell · 2015 · 155 citations

Medicine, Pharmacology, Pharmacotherapy +13

Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers

Stéphane Ferretti, Jacques Hamon, Ruben de Kanter et al. · Nature · 2024 · 113 citations · Full text

Life Sciences, Oncology, Pharmacology +17

JAK1/2 and Pan-Deacetylase Inhibitor Combination Therapy Yields Improved Efficacy in Preclinical Mouse Models of JAK2V617F-Driven Disease

Emeline Evrot, Nicolas Ebel, Vincent Romanet et al. · Clinical Cancer Research · 2013 · 82 citations

Medicine, Pharmacology, Pharmacotherapy +14

Hyaluronidase Increases Electrogene Transfer Efficiency in Skeletal Muscle

Carmela Mennuni, Francesco Calvaruso, Immacolata Zampaglione et al. · Human Gene Therapy · 2002 · 63 citations

Life Sciences, Bioengineering, Biotechnology +14